Study confirms efficacy and safety of apremilast for treatment of plaques psoriasis MD Editorial Team4 Nov 2021 9:00 AM ISTItaly: Apremilast in real-life experience confirmed the levels of safety and efficacy obtained in pivotal trials for the treatment of treat plaque...
Use of some biologics increase risk of serious infections in psoriasis patients: JAMA MD Editorial Team14 Oct 2021 9:00 AM ISTFrance: A new study by Laetitia Penso and colleagues reported that the risk of serious infections is increased in new users of infliximab and...
Psoriatic arthritis medications increase risk of adverse CV events: Study MD Editorial Team5 Oct 2021 9:00 AM ISTFrance: An analysis of a large database indicated a modest overall number of major adverse cardiovascular events (MACEs), with the risk of MACEs being...
Unichem Labs plaque psoriasis drug Apremilast gets USFDA nod Ruchika Sharma19 Feb 2021 2:00 PM ISTMumbai: Unichem Laboratories Limited, today announced that the company has received abbreviated new drug application (ANDA) approval for its...
Apremilast safe for psoriasis in elderly patients: study claims Dr Satabdi Saha10 Aug 2020 5:45 PM ISTAccording to a retrospective, real-world study, Apremilast, a drug recently developed for psoriasis have proved to be effective and safe in elderly...
